Treatment of Alzheimer's disease with anti-homocysteic acid antibody in 3xTg-AD male mice.
Alzheimer's disease (AD) is an age-associated progressive neurodegenerative disorder with dementia, the exact pathogenic mechanisms of which remain unknown. We previously reported that homocysteic acid (HA) may be one of the pathological biomarkers in the brain with AD and that the increased le...
Main Authors: | Tohru Hasegawa, Nobuyuki Mikoda, Masashi Kitazawa, Frank M LaFerla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2808336?pdf=render |
Similar Items
-
Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition
by: David Baglietto-Vargas, et al.
Published: (2014-02-01) -
Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.
by: Nicholas A Castello, et al.
Published: (2012-01-01) -
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice
by: Lani K. Clinton, et al.
Published: (2007-10-01) -
Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
by: Yesica Gloria, et al.
Published: (2021-09-01) -
Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
by: Darlene A. Mitrano, et al.
Published: (2021-06-01)